27 June 2024 - Concerns have been raised about the relative effectiveness of an increasing number of new medicines at the time of their market authorisation, a spokesperson for outgoing Dutch Medical Care Minister Pia Dijkstra told Euractiv.

The spokesperson was responding to questions about a letter Dijkstra sent to the Dutch House of Representatives in April in which she outlined her plans to reform the system for the reimbursement of new high cost medicines.

Read Euractiv article